News: Darrell J. Irvine

Engineers use “DNA origami” to identify vaccine design rules

June 30, 2020

more

Enhancing cancer immunotherapy with nanomedicine

February 14, 2020

more

Deshpande Center and J-WAFS announce fall 2017 research grants

October 17, 2017

The MIT Deshpande Center for Technological Innovation announced today the award of $768,000 in grants to 17 MIT research teams currently working on early-stage technologies. DMSE-related projects include: "Structured Nucleic Acid Nanoparticle Therapeutic Delivery Platform" — Mark Bathe,…  more

Converging on cancer at the nanoscale

July 10, 2017

This summer, the Koch Institute for Integrative Cancer Research at MIT marks the first anniversary of the launch of the Marble Center for Cancer Nanomedicine. The Marble Center for Cancer Nanomedicine focuses on grand challenges in cancer detection, treatment, and monitoring that can…  more

Fighting cancer with the power of immunity

October 26, 2016

Professor Darrell Irvine was a senior author alongside Dane Wittrup for a study published to the online edition of Nature Medicine on Oct. 24.  "Harnessing the body’s own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However…  more

Prof. Irvine to speak at US Frontiers of Engineering

July 29, 2016

Prof. Darrell Irvine has been selected to participate in the 2016 US Frontiers of Engineering Symposium in Irvine, CA this September from the 19th to the 21st.  Prof. Irvine will present a talk entitled "…  more

Materializing the Future of Vaccines and Immunotherapy

January 25, 2016

The industries of immunotherapy and vaccination are on the brink of major breakthroughs, and many developments in the field are heavily focused on materials science. Safely modulating the immune system in patients with cancer is one of the biggest challenges at present, but developments in…  more

Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.

May 22, 2015

MIT researchers have shown that they can use a microfluidic cell-squeezing device to introduce specific antigens inside the immune system’s B cells, providing a new approach to developing and implementing antigen-presenting cell vaccines. Such vaccines, created by reprogramming a patient’…  more

Professor Darrell Irvine named AIMBE Fellow

March 11, 2015

Darrell J Irvine To be Inducted into Medical and Biological Engineering Elite WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Darrell J. Irvine, Ph.D., Professor of Biological Engineering and Materials Science…  more

Vaccine Delivery

February 17, 2014

Professor Darrell Irvine has published research on new vaccines that catch a ride to immune cell depots in order to help fight cancer and HIV. See the MIT…  more

Nanoparticle vaccine offers better protection

September 25, 2013

Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases. See the News Office for the full story.  more

Polymer films used in vaccinations

January 27, 2013

A polymer film that gradually releases DNA coding for viral proteins could offer a better alternative to traditional vaccines;  Professor Darrell Irvine and his collaborators are working on just such a technology.  See the…  more

Prof. Irvine and colleagues are working on an AIDS vaccine

October 18, 2012

Prof. Darrell Irvine and colleagues Darrell Irvine have received funding to break down silos of scientific disciplines to create an AIDS vaccine.  Learn more from…  more

Lunch and Lecture, April 14, Prof. Darrell Irvine

April 11, 2010

Combining cell therapy and nanoparticle drug delivery: Chemical cell surface engineering on live cells using nanoparticles
Darrell J. Irvine, Associate Professor of Materials Science and Engineering & Biological Engineering
Wednesday, April 14
12:…  more

Prof. Irvine profiled in Spectrum

October 1, 2009

Spectrum, a magazine from the MIT Office of Resource Development, profiled Prof. Darrell J. Irvine and his work on new materials that help the immune system fight disease.  more